European scientists set up new therapeutic approaches to tackle specific Lysosomal Storage Disorders: a new drug combination and enzyme replacement therapy against Pompe disease and gene therapy against MPS V I (Mucopolysaccharidosis VI).

Talking or reading. Texting a message or listening. The dilemma of choosing between various tasks is not an invention of the modern information age. Humans and all vertebrates have to prioritise their actions.

We can blame all sorts of things on the weather. But a stomach bug?  It seems unlikely. Yet, scientists say greater quantities of rainfall and bigger storms will lead to more stomach upsets in parts of Europe.

It is a damning neologism of our age, a new word combining the threat of two major health problems of epidemic-like proportions. In Europe alone, around 33 million adults are expected to be suffering from type-2 diabetes by 2010.

Bacteria and other microorganisms that cause infections are remarkably resilient and can develop ways to survive drugs meant to kill or weaken them.